Latest Headlines

Latest Headlines

Novartis remediation drags on longer than expected

In reporting an 8% first-quarter earnings decline to shareholders, Novartis acknowledged the company's inability to meet GMPs at a variety of plants played a big role in that dip.

FDA report shows deep problems at closed Novartis Consumer Health plant

With the completion of inspections Jan. 20, Novartis Consumer Health ($NVS) set about reviewing the 483 FDA observations of its idled plant in Lincoln, NE. The plant was voluntarily closed Dec. 19 to...

Novartis says Nebraska plant to reopen midyear

The Novartis ($NVS) Nebraska plant closed in December because a host of over-the-counter products contained stray pieces from other drugs is expected to reopen this summer. Twice in recent days...